Exelixis
EXEL
#1326
Rank
S$20.73 B
Marketcap
S$84.98
Share price
0.14%
Change (1 day)
54.42%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company